Mon, October 22, 2018
Fri, October 19, 2018
Thu, October 18, 2018

Aaron Gal Downgraded (BIIB) to Hold on, Oct 19th, 2018

Aaron Gal of Bernstein, Downgraded "Biogen Inc." (BIIB) to Hold on, Oct 19th, 2018.

Aaron has made no other calls on BIIB in the last 4 months.



There are 8 other peers that have a rating on BIIB. Out of the 8 peers that are also analyzing BIIB, 2 agree with Aaron's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $320 on, Wednesday, July 25th, 2018
  • Brian Skorney of "Baird" Maintained at Hold with Increased Target to $348 on, Wednesday, July 25th, 2018


These are the ratings of the 6 analyists that currently disagree with Aaron


  • Alethia Young of "Cantor Fitzgerald" Initiated at Buy and Held Target at $400 on, Monday, October 1st, 2018
  • Thomas Shrader of "Stifel" Initiated at Strong Buy and Held Target at $394 on, Tuesday, August 7th, 2018
  • Carter Gould of "UBS" Maintained at Strong Buy with Increased Target to $395 on, Thursday, July 26th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $392 on, Wednesday, July 25th, 2018
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $396 on, Monday, July 23rd, 2018
  • Robyn Karnauskas of "Citigroup" Upgraded from Hold to Strong Buy and Held Target at $371 on, Friday, July 6th, 2018